EE200100663A - Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks - Google Patents

Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks

Info

Publication number
EE200100663A
EE200100663A EEP200100663A EEP200100663A EE200100663A EE 200100663 A EE200100663 A EE 200100663A EE P200100663 A EEP200100663 A EE P200100663A EE P200100663 A EEP200100663 A EE P200100663A EE 200100663 A EE200100663 A EE 200100663A
Authority
EE
Estonia
Prior art keywords
treatment
cardiovascular diseases
aminotetraline
derivative
aminotetraline derivative
Prior art date
Application number
EEP200100663A
Other languages
English (en)
Estonian (et)
Inventor
Bongrani Stefano
Razzetti Roberta
Civelli Maurizio
Umile Alberto
Chiesi Paolo
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/328,434 external-priority patent/US6103760A/en
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Priority claimed from PCT/EP2000/005231 external-priority patent/WO2000076544A1/en
Publication of EE200100663A publication Critical patent/EE200100663A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200100663A 1999-06-09 2000-06-07 Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks EE200100663A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/328,434 US6103760A (en) 1995-03-17 1999-06-09 Aminotetralin derivative for the therapy of cardiovascular diseases
PCT/EP2000/005231 WO2000076544A1 (en) 1996-03-13 2000-06-07 Aminotetralin derivative for the therapy of cardiovascular diseases

Publications (1)

Publication Number Publication Date
EE200100663A true EE200100663A (et) 2003-04-15

Family

ID=23280968

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100663A EE200100663A (et) 1999-06-09 2000-06-07 Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks

Country Status (27)

Country Link
US (2) US6576671B1 (xx)
EP (1) EP1183046B1 (xx)
JP (1) JP2003501483A (xx)
KR (1) KR20020005772A (xx)
CN (1) CN1354676A (xx)
AT (1) ATE248607T1 (xx)
AU (1) AU766230B2 (xx)
BR (1) BR0012121A (xx)
CA (1) CA2376715A1 (xx)
CZ (1) CZ20014406A3 (xx)
DE (1) DE60004996T2 (xx)
DK (1) DK1183046T3 (xx)
EA (1) EA003830B1 (xx)
EE (1) EE200100663A (xx)
ES (1) ES2206240T3 (xx)
HK (1) HK1044279B (xx)
HU (1) HUP0201650A2 (xx)
IL (1) IL146962A0 (xx)
MA (1) MA26796A1 (xx)
MX (1) MXPA01012638A (xx)
NO (1) NO20016000L (xx)
NZ (1) NZ515727A (xx)
PL (1) PL352119A1 (xx)
PT (1) PT1183046E (xx)
SK (1) SK18012001A3 (xx)
TR (1) TR200103526T2 (xx)
ZA (1) ZA200110091B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10053397A1 (de) 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20050101668A1 (en) * 2003-07-24 2005-05-12 Chiesi Farmaceutici S.P.A. Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions
EP1500392A1 (en) * 2003-07-24 2005-01-26 CHIESI FARMACEUTICI S.p.A. Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134997A (en) * 1977-03-01 1979-01-16 University Of Iowa Research Foundation Effect of an aminotetralin derivative on coronary blood flow in infarcted hearts
IT1275935B1 (it) * 1995-03-17 1997-10-24 Chiesi Farma Spa Derivato di aminotetralina per la terapia di malattie cardiovascolari

Also Published As

Publication number Publication date
PL352119A1 (en) 2003-07-28
CZ20014406A3 (cs) 2002-04-17
ZA200110091B (en) 2002-12-09
EP1183046B1 (en) 2003-09-03
TR200103526T2 (tr) 2002-04-22
MXPA01012638A (es) 2002-07-22
SK18012001A3 (sk) 2002-04-04
JP2003501483A (ja) 2003-01-14
NO20016000L (no) 2002-02-11
DE60004996T2 (de) 2004-07-22
CN1354676A (zh) 2002-06-19
KR20020005772A (ko) 2002-01-17
NO20016000D0 (no) 2001-12-07
DE60004996D1 (de) 2003-10-09
EA003830B1 (ru) 2003-10-30
NZ515727A (en) 2003-06-30
BR0012121A (pt) 2002-05-14
PT1183046E (pt) 2003-12-31
HK1044279A1 (en) 2002-10-18
HUP0201650A2 (hu) 2002-12-28
EP1183046A1 (en) 2002-03-06
IL146962A0 (en) 2002-08-14
MA26796A1 (fr) 2004-12-20
ES2206240T3 (es) 2004-05-16
ATE248607T1 (de) 2003-09-15
CA2376715A1 (en) 2000-12-21
AU5076500A (en) 2001-01-02
EA200101159A1 (ru) 2002-06-27
AU766230B2 (en) 2003-10-09
DK1183046T3 (da) 2004-01-05
HK1044279B (zh) 2004-01-16
US6576671B1 (en) 2003-06-10
US20030207944A1 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
DE60329001D1 (en) 8-hydroxychinolinderivate
WO2006081431A3 (en) Compounds for treating inflammatory and demyelinating diseases
HK1069339A1 (en) Substituted diketopiperazines as oxytocin antagonists
MXPA04003245A (es) Hidroxipropilaminas.
MY119375A (en) Treatment of tinnitus using neuroprotective agents
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
CA2383785A1 (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
EE200100663A (et) Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks
HK1080768A1 (en) Use of epothilone derivatives for the treatment ofhyperparathyroidism
MX9604692A (es) Derivados de quinoxalina para el tratamiento de tinnitus.
TNSN99158A1 (ar) طريقة لمنع الاصابة بالربو
NO20003785D0 (no) Anvendelse av 2-amino-6-trifluormetoksy-benzotiazol for prevensjon eller terapi av cerebellum dysfunksjon
EP1331004A3 (en) Aminotetralin Derivative for the Therapy of Cardiovascular Diseases
US6541495B1 (en) Carboxylic acid derivatives as inhibitors of hyperproliferation diseases
YU59102A (sh) JEDINJENJA KORISNA ZA LEČENJE ILI PREVENCIJU OBOLJENJA U KOJEM UČESTVUJE ALFA-2β-ADRENOCEPTOR
NO20014889L (no) Fremgangsmåte for fremstilling av medisinske midler
MX9605153A (es) Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas.
LV12459A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai